However, it is an open question whether this additional upregulation is relevant for the success of ICB therapy, because, in untreated tumor-bearing λ-MYC mice, costimulatory molecules on DCs were also elevated in comparison to normal mice and an anergization of T cells owing to a lack of costimuli is, therefore, unlikely to account for immune escape [24]. This evidence concerns the gene MYC and neoplasm.